儿童质子泵抑制剂合理使用专家共识2019

2020-02-29 中华医学会儿科学分会临床药理学组 中国实用儿科杂志.2019,34(12):977-981.

质子泵抑制剂(proton pump inhibitors,PPIs,又称胃H+/K+-ATP酶抑制剂)能够特异性和非竞争性地作用于H+/K+-ATP酶,阻断各种原因所致壁细胞泌酸的共同及最终环节,具有强力抑酸作用,是迄今抑酸作用最强的药物。临床广泛应用于胃、十二指肠溃疡以及胃-食管反流病、上消化道出血和卓-艾综合征(又称胃泌素瘤)等各种酸相关疾病的治疗及预防应激所致的胃黏膜损伤。但其在儿童中的应

中文标题:

儿童质子泵抑制剂合理使用专家共识2019

发布日期:

2020-02-29

简要介绍:

质子泵抑制剂(proton pump inhibitors,PPIs,又称胃H+/K+-ATP酶抑制剂)能够特异性和非竞争性地作用于H+/K+-ATP酶,阻断各种原因所致壁细胞泌酸的共同及最终环节,具有强力抑酸作用,是迄今抑酸作用最强的药物。临床广泛应用于胃、十二指肠溃疡以及胃-食管反流病、上消化道出血和卓-艾综合征(又称胃泌素瘤)等各种酸相关疾病的治疗及预防应激所致的胃黏膜损伤。但其在儿童中的应用目前仍缺乏合理使用依据,存在适应证不明确、用药剂量及疗程不规范等问题。为进一步提高儿科医生对PPIs用药合理性的认识,中华医学会儿科学分会临床药理学组、中华医学会儿科学分会消化学组、中国医药教育协会儿童用药临床评价分会、国家儿童医学临床研究中心(重庆)及《中国实用儿科杂志》编辑委员会组织相关专家联合制定本共识,为儿科PPIs临床合理使用提供依据和指导。

 

拓展指南:质子泵抑制剂相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003479, encodeId=fdc310034e933, content=好的很!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/0a5a89559683459abe456c6834f523c6/bc83ed060c254037bd769861d8b50ad4.jpg, createdBy=0f3f4721692, createdName=Dr.Maggie, createdTime=Wed Jul 28 23:11:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951585, encodeId=28af951585da, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7981424416, createdName=476661659, createdTime=Sat Mar 27 11:49:31 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947003, encodeId=4d4694e003c4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c22614179, createdName=ywf0923, createdTime=Wed Mar 10 08:55:47 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944377, encodeId=ce3b9443e763, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Mar 01 11:08:20 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919267, encodeId=fe1791926ed7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5895455182, createdName=ms9000000777115696, createdTime=Sat Jan 23 19:27:50 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-07-28 Dr.Maggie

    好的很!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003479, encodeId=fdc310034e933, content=好的很!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/0a5a89559683459abe456c6834f523c6/bc83ed060c254037bd769861d8b50ad4.jpg, createdBy=0f3f4721692, createdName=Dr.Maggie, createdTime=Wed Jul 28 23:11:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951585, encodeId=28af951585da, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7981424416, createdName=476661659, createdTime=Sat Mar 27 11:49:31 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947003, encodeId=4d4694e003c4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c22614179, createdName=ywf0923, createdTime=Wed Mar 10 08:55:47 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944377, encodeId=ce3b9443e763, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Mar 01 11:08:20 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919267, encodeId=fe1791926ed7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5895455182, createdName=ms9000000777115696, createdTime=Sat Jan 23 19:27:50 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-03-27 476661659

    不错不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003479, encodeId=fdc310034e933, content=好的很!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/0a5a89559683459abe456c6834f523c6/bc83ed060c254037bd769861d8b50ad4.jpg, createdBy=0f3f4721692, createdName=Dr.Maggie, createdTime=Wed Jul 28 23:11:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951585, encodeId=28af951585da, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7981424416, createdName=476661659, createdTime=Sat Mar 27 11:49:31 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947003, encodeId=4d4694e003c4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c22614179, createdName=ywf0923, createdTime=Wed Mar 10 08:55:47 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944377, encodeId=ce3b9443e763, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Mar 01 11:08:20 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919267, encodeId=fe1791926ed7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5895455182, createdName=ms9000000777115696, createdTime=Sat Jan 23 19:27:50 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-03-10 ywf0923

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1003479, encodeId=fdc310034e933, content=好的很!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/0a5a89559683459abe456c6834f523c6/bc83ed060c254037bd769861d8b50ad4.jpg, createdBy=0f3f4721692, createdName=Dr.Maggie, createdTime=Wed Jul 28 23:11:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951585, encodeId=28af951585da, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7981424416, createdName=476661659, createdTime=Sat Mar 27 11:49:31 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947003, encodeId=4d4694e003c4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c22614179, createdName=ywf0923, createdTime=Wed Mar 10 08:55:47 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944377, encodeId=ce3b9443e763, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Mar 01 11:08:20 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919267, encodeId=fe1791926ed7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5895455182, createdName=ms9000000777115696, createdTime=Sat Jan 23 19:27:50 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-03-01 12314969m72暂无昵称

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1003479, encodeId=fdc310034e933, content=好的很!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/0a5a89559683459abe456c6834f523c6/bc83ed060c254037bd769861d8b50ad4.jpg, createdBy=0f3f4721692, createdName=Dr.Maggie, createdTime=Wed Jul 28 23:11:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951585, encodeId=28af951585da, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7981424416, createdName=476661659, createdTime=Sat Mar 27 11:49:31 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947003, encodeId=4d4694e003c4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6c22614179, createdName=ywf0923, createdTime=Wed Mar 10 08:55:47 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944377, encodeId=ce3b9443e763, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Mar 01 11:08:20 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919267, encodeId=fe1791926ed7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5895455182, createdName=ms9000000777115696, createdTime=Sat Jan 23 19:27:50 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 ms9000000777115696

    学习好资料

    0